NEW YORK (GenomeWeb News) — Pfizer Canada has given CA$500,000 ($440,000) to a Canadian research project studying the pharmacogenomics of pediatric drug toxicity, the company said today.
 
The project, Genotype-Specific Approaches to Therapy in Childhood initiative, or GATC, plans to study DNA from children who have experienced adverse drug reactions in hopes of identifying biomarkers linked to severe drug toxicity.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.